The forecast for systemic hormonal preparations sales in Italy, excluding sex hormones and insulins, indicates growth from 2024 through 2028, with values rising from $14.2 to $15.4 US Dollars PPP per capita. In 2023, the value stood at approximately $14.0. The forecasted year-on-year growth is consistent and suggests increasing demand or market expansion. Over the last two years, growth averages around 2.1% per year.
Future trends to watch for include:
- Potential market innovations and new systemic hormonal products.
- Regulatory changes impacting market dynamics.
- Shifts in healthcare policies affecting availability and prescribing habits.
